The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review
Open accessAbstract
Bacteriophages are not forgotten viruses anymore: scientists and practitioners seek to understand phage pharmacokinetics in animals and humans, investigating bacteriophages as therapeutics, nanocarriers or microbiome components. This review provides a comprehensive overview of factors that determine phage circulation, penetration, and clearance, and that in consequence determine phage applicability for medicine. It makes use of experimental data collected by the phage community so far (PubMed 1924‐2016, including non‐English reports), combining elements of critical and systematic review. This study covers phage ability to enter a system by various routes of administration, how (and if) the phage may access various tissues and organs, and finally what mechanisms determine the courses of phage clearance. The systematic review method was applied to analyze (i) phage survival in the gut (gut transit) and (ii) phage ability to enter the mammalian system by many administration routes. Aspects that have not yet been covered by a sufficient number of reports for mathematical analysis, as well as mechanisms underlying trends, are discussed in the form of a critical review. In spite of the extraordinary diversity of bacteriophages and possible phage applications, the analysis revealed that phage morphology, phage specificity, phage dose, presence of sensitive bacteria or the characteristics of treated individuals (age, taxonomy) may affect phage bioavailability in animals and humans. However, once phages successfully enter the body, they reach most organs, including the central nervous system. Bacteriophages are cleared mainly by the immune system: innate immunity removes phages even when no specific response to bacteriophages has yet developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cao, Z., Zhang, J., Niu, Y. D., Cui, N., Ma, Y., Cao, F., Jin, L., Li, Z., & Xu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116571 · Cited by 59
RetractedRenal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Kararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
The influence of external factors on bacteriophages—review
Jończyk, E., Kłak, M., Międzybrodzki, R., & Górski, A. (2011) · Folia Microbiologica · doi:10.1007/s12223-011-0039-8 · Cited by 705
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
McConnell, E. L., Basit, A. W., & Murdan, S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0008 · Cited by 654
Intraluminal pH of the human gastrointestinal tract.
Fallingborg, J. (1999) · PubMed · Cited by 630
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy
Bruttin, A., & Brüssow, H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2874-2878.2005 · Cited by 563
Sarker, S. A., Sultana, S., Reuteler, G., Moine, D., Descombes, P., Charton, F., Bourdin, G., McCallin, S., Ngom-Bru, C., Neville, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.023 · Cited by 533
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
THE EVOLUTION OF ADAPTIVE IMMUNITY
Pancer, Z., & Cooper, M. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090542 · Cited by 513
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Going viral: next-generation sequencing applied to phage populations in the human gut
Reyes, A., Semenkovich, N. P., Whiteson, K., Rohwer, F., & Gordon, J. I. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2853 · Cited by 441
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Multiple facets of intestinal permeability and epithelial handling of dietary antigens
Ménard, S., Cerf-Bensussan, N., & Heyman, M. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.5 · Cited by 410
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers
Nguyen, S., Baker, K., Padman, B. S., Patwa, R., Dunstan, R. A., Weston, T. A., Schlosser, K., Bailey, B., Lithgow, T., Lazarou, M., et al. (2017) · mBio · doi:10.1128/mbio.01874-17 · Cited by 378
Clinical Aspects of Phage Therapy
Międzybrodzki, R., Borysowski, J., Weber-Dąbrowska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawełczyk, Z., Rogóż, P., Kłak, M., Wojtasik, E., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00003-7 · Cited by 373
Rohwer, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00276-9 · Cited by 370
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
Furfaro, L. L., Payne, M. S., & Chang, B. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00376 · Cited by 362
The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome
Beasley, D. E., Koltz, A. M., Lambert, J. E., Fierer, N., & Dunn, R. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134116 · Cited by 346
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
The human gut microbiota and virome: Potential therapeutic implications
Scarpellini, E., Ianiro, G., Attili, F., Bassanelli, C., De Santis, A., & Gasbarrini, A. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.07.008 · Cited by 315
Phage therapy reduces Campylobacter jejuni colonization in broilers
Wagenaar, J. A., Bergen, M. A. P. V., Mueller, M. A., Wassenaar, T. M., & Carlton, R. M. (2005) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.06.002 · Cited by 314
Microencapsulation of Bacteriophage Felix O1 into Chitosan-Alginate Microspheres for Oral Delivery
Ma, Y., Pacan, J. C., Wang, Q., Xu, Y., Huang, X., Korenevsky, A., & Sabour, P. M. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00246-08 · Cited by 306
Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model
McVay, C. S., Velásquez, M., & Fralick, J. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-06 · Cited by 306
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L. (2010) · The Journal of Infectious Diseases · doi:10.1086/651135 · Cited by 304
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Self-citationExperimental Phage Therapy against Staphylococcus aureus in Mice
Capparelli, R., Parlato, M., Borriello, G., Salvatore, P., & Iannelli, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01513-06 · Cited by 300
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
The Role of the Complement System in Innate Immunity
Rus, H., Cudrici, C., & Niculescu, F. (2005) · Immunologic Research · doi:10.1385/ir:33:2:103 · Cited by 288
Phage as a Modulator of Immune Responses
Górski, A., Międzybrodzki, R., Borysowski, J., Dąbrowska, K., Wierzbicki, P., Ohams, M., Korczak-Kowalska, G., Olszowska-Zaremba, N., Łusiak-Szelachowska, M., Kłak, M., et al. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00002-5 · Cited by 266
Self-citationMatsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., Shen, Y., Jin, Z., Fujimoto, S., Nasimuzzaman, M. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/374001 · Cited by 260
Transdermal protein delivery by a coadministered peptide identified via phage display
Chen, Y., Shen, Y., Guo, X., Zhang, C., Yang, W., Ma, M., Liu, S., Zhang, M., & Wen, L.-P. (2006) · Nature Biotechnology · doi:10.1038/nbt1193 · Cited by 249
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Van Belleghem, J. D., Clement, F., Merabishvili, M., Lavigne, R., & Vaneechoutte, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-08336-9 · Cited by 244
Viertel, T. M., Ritter, K., & Horz, H.-P. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku173 · Cited by 243
Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh
Sarker, S. A., McCallin, S., Barretto, C., Berger, B., Pittet, A.-C., Sultana, S., Krause, L., Huq, S., Bibiloni, R., Bruttin, A., et al. (2012) · Virology · doi:10.1016/j.virol.2012.09.002 · Cited by 240
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Ryan, E. M., Gorman, S. P., Donnelly, R. F., & Gilmore, B. F. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01324.x · Cited by 227
Górski, A., Ważna, E., DÄ browska, B.-W., DÄ browska, K., ÅwitaÅa-JeleÅ, K., & MiÄdzybrodzki, R. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00044.x · Cited by 227
Self-citationDark Matter of the Biosphere: the Amazing World of Bacteriophage Diversity
Hatfull, G. F. (2015) · Journal of Virology · doi:10.1128/jvi.01340-15 · Cited by 225
Liposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella spp
Colom, J., Cano-Sarabia, M., Otero, J., Cortés, P., Maspoch, D., & Llagostera, M. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00812-15 · Cited by 223
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
Ochs, H. D., Davis, S. D., & Wedgwood, R. J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106756 · Cited by 219
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
A bacteriophages journey through the human body
Barr, J. J. (2017) · Immunological Reviews · doi:10.1111/imr.12565 · Cited by 216
Experimental phage therapy of burn wound infection: difficult first steps.
Rose, T., Verbeken, G., Vos, D. D., Merabishvili, M., Vaneechoutte, M., Lavigne, R., Jennes, S., Zizi, M., & Pirnay, J. (2014) · PubMed · Cited by 213
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1127 · Cited by 202
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail
Nakai, T., Sugimoto, R., Park, K., Matsuoka, S., Mori, K., Nishioka, T., & Maruyama, K. (1999) · Diseases of Aquatic Organisms · doi:10.3354/dao037033 · Cited by 198
Microencapsulation with alginate/CaCO3: A strategy for improved phage therapy
Colom, J., Cano-Sarabia, M., Otero, J., Aríñez-Soriano, J., Cortés, P., Maspoch, D., & Llagostera, M. (2017) · Scientific Reports · doi:10.1038/srep41441 · Cited by 197
Tanji, Y., Shimada, T., Fukudomi, H., Miyanaga, K., Nakai, Y., & Unno, H. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.280 · Cited by 196
Chhibber, S., Kaur, S., & Kumari, S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/002873-0 · Cited by 194
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
Oral Application of T4 Phage Induces Weak Antibody Production in the Gut and in the Blood
Majewska, J., Beta, W., Lecion, D., Hodyra-Stefaniak, K., Kłopot, A., Kaźmierczak, Z., Miernikiewicz, P., Piotrowicz, A., Ciekot, J., Owczarek, B., et al. (2015) · Viruses · doi:10.3390/v7082845 · Cited by 186
Self-citationImmunogenicity Studies of Proteins Forming the T4 Phage Head Surface
Dąbrowska, K., Miernikiewicz, P., Piotrowicz, A., Hodyra, K., Owczarek, B., Lecion, D., Kaźmierczak, Z., Letarov, A., & Górski, A. (2014) · Journal of Virology · doi:10.1128/jvi.02043-14 · Cited by 185
Self-citationFilamentous phage as vector-mediated antibody delivery to the brain
Frenkel, D., & Solomon, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072027199 · Cited by 180
Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice
Cerveny, K. E., DePaola, A., Duckworth, D. H., & Gulig, P. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6251-6262.2002 · Cited by 179
Bacteriophage T4 Infection of Stationary Phase E. coli: Life after Log from a Phage Perspective
Bryan, D. W., El‐Shibiny, A., Hobbs, Z., Porter, J., & Kutter, E. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01391 · Cited by 169
Convection-enhanced delivery for the treatment of brain tumors
Debinski, W., & Tatter, S. B. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.99 · Cited by 168
Singla, S., Harjai, K., Katare, O. P., & Chhibber, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153777 · Cited by 163
Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., Li, X., Cao, Z., Zhang, J., Jin, L., et al. (2015) · BioMed Research International · doi:10.1155/2015/752930 · Cited by 159
Galtier, M., Sordi, L. D., Maura, D., Arachchi, H., Volant, S., Dillies, M., & Debarbieux, L. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13284 · Cited by 157
Górski, A., Międzybrodzki, R., Weber‐Dąbrowska, B., Fortuna, W., Letkiewicz, S., Rogóż, P., Jończyk‐Matysiak, E., Dąbrowska, K., Majewska, J., & Borysowski, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01515 · Cited by 156
Self-citationHousby, J. N., & Mann, N. H. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.006 · Cited by 155
Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary Infection
Carmody, L. A., Gill, J. J., Summer, E. J., Sajjan, U. S., Gonzalez, C. F., Young, R., & LiPuma, J. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/649227 · Cited by 154
Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray
HUFF, W. E., Huff, G. R., Rath, N., Balog, J., & Donoghue, A. (2002) · Poultry Science · doi:10.1093/ps/81.10.1486 · Cited by 153
Górski, A., Dąbrowska, K., Międzybrodzki, R., Weber‐Dąbrowska, B., Łusiak-Szelachowska, M., Jończyk‐Matysiak, E., & Borysowski, J. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0049 · Cited by 149
Self-citationPredicting In Vivo Efficacy of Therapeutic Bacteriophages Used To Treat Pulmonary Infections
Henry, M., Lavigne, R., & Debarbieux, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01596-13 · Cited by 148
Pouillot, F., Chomton, M., Blois, H., Courroux, C., Noelig, J., Bidet, P., Bingen, É., & Bonacorsi, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06330-11 · Cited by 145
Bacteriophage Ecology in Commercial Sauerkraut Fermentations
Lu, Z., Breidt, F., Plengvidhya, V., & Fleming, H. P. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.6.3192-3202.2003 · Cited by 143
Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome
Zhvania, P., Hoyle, N. S., Nadareishvili, L., Nizharadze, D., & Kutateladze, M. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00094 · Cited by 140
Oral Delivery Systems for Encapsulated Bacteriophages Targeted at O157:H7 in Feedlot Cattle
Stanford, K., McAllister, T. A., Niu, Y. D., Stephens, T. P., Mazzocco, A., Waddell, T. E., & Johnson, R. P. (2010) · Journal of Food Protection · doi:10.4315/0362-028x-73.7.1304 · Cited by 136
Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption
Attili-Qadri, S., Karra, N., Nemirovski, A., Schwob, O., Talmon, Y., Nassar, T., & Benita, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313839110 · Cited by 135
Wolochow, H., Hildebrand, G. J., & Lamanna, C. (1966) · The Journal of Infectious Diseases · doi:10.1093/infdis/116.4.523 · Cited by 133
Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model
Trigo, G., Martins, T. G., Fraga, A. G., Longatto‐Filho, A., Castro, A. G., Azeredo, J., & Pedrosa, J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002183 · Cited by 132
Kim, K.-P., Cha, J., Jang, E., Klumpp, J., Hagens, S., Hardt, W., Lee, K., & Loessner, M. J. (2008) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00028.x · Cited by 128
Jun, J. W., Shin, T. H., Kim, J. H., Shin, S. P., Han, J. E., Heo, G. J., Zoysa, M. D., Shin, G. W., Chai, J. Y., & Park, S. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu059 · Cited by 126
Dubos, R. J., Straus, J. H., & Pierce, C. (1943) · The Journal of Experimental Medicine · doi:10.1084/jem.78.3.161 · Cited by 123
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy
Capparelli, R., Nocerino, N., Iannaccone, M., Ercolini, D., Parlato, M., Medaglia, C., & Iannelli, D. (2009) · The Journal of Infectious Diseases · doi:10.1086/648478 · Cited by 120
Navarro, F., & Muniesa, M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00566 · Cited by 118
Phage therapy of pulmonary infections
Abedon, S. T. (2015) · Bacteriophage · doi:10.1080/21597081.2015.1020260 · Cited by 117
T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production
Miernikiewicz, P., Dąbrowska, K., Piotrowicz, A., Owczarek, B., Wojas-Turek, J., Kicielińska, J., Rossowska, J., Pajtasz‐Piasecka, E., Hodyra‐Stefaniak, K., Macegoniuk, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071036 · Cited by 115
Self-citationMarine phage genomics: what have we learned?
Paul, J. H., & Sullivan, M. B. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.03.007 · Cited by 114
In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli
Weiss, M., Denou, E., Bruttin, A., Serra-Moreno, R., Dillmann, M.-L., & Brüssow, H. (2009) · Virology · doi:10.1016/j.virol.2009.07.020 · Cited by 113
Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections
Semler, D. D., Goudie, A. D., Finlay, W. H., & Dennis, J. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02388-13 · Cited by 113
Properdin: a tightly regulated critical inflammatory modulator
Blatt, A. Z., Pathan, S., & Ferreira, V. P. (2016) · Immunological Reviews · doi:10.1111/imr.12466 · Cited by 113
T4 phages against Escherichia coli diarrhea: Potential and problems
Denou, E., Bruttin, A., Barretto, C., Ngom‐Bru, C., Brüssow, H., & Zuber, S. (2009) · Virology · doi:10.1016/j.virol.2009.03.009 · Cited by 112
Paul, J. H., Sullivan, M. B., Segall, A. M., & Rohwer, F. L. (2002) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(02)00168-9 · Cited by 110
Jamalludeen, N., Johnson, R. P., Shewen, P. E., & Gyles, C. L. (2008) · Veterinary Microbiology · doi:10.1016/j.vetmic.2008.10.021 · Cited by 108
Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models
Tiwari, B. R., Kim, S., Rahman, M., & Kim, J. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1512-4 · Cited by 105
Studies on bacteriophage penetration in patients subjected to phage therapy.
Weber‐Dąbrowska, B., Dabrowski, M., & Šlopek, S. (1987) · PubMed · Cited by 105
Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
Maura, D., Galtier, M., Bouguénec, C. L., & Debarbieux, L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-12 · Cited by 104
Facing Antibiotic Resistance: Staphylococcus aureus Phages as a Medical Tool
Kaźmierczak, Z., Górski, A., & Dąbrowska, K. (2014) · Viruses · doi:10.3390/v6072551 · Cited by 103
Self-citationMaura, D., Morello, E., du Merle, L., Bomme, P., Bouguénec, C. L., & Debarbieux, L. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02644.x · Cited by 99
The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage.
Inchley, C. J. (1969) · PubMed Central · Cited by 98
T4 Phage Tail Adhesin Gp12 Counteracts LPS-Induced Inflammation In Vivo
Miernikiewicz, P., Kłopot, A., Soluch, R., Szkuta, P. T., Kęska, W., Hodyra‐Stefaniak, K., Konopka, A., Nowak, M., Lecion, D., Kaźmierczak, Z., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01112 · Cited by 98
Self-citationAdvances in the transepithelial transport of nanoparticles
Yu, M., Yang, Y., Zhu, C., Guo, S., & Gan, Y. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.007 · Cited by 97
Antiphage Activity of Sera During Phage Therapy in Relation to its Outcome
Łusiak-Szelachowska, M., Żaczek, M., Weber‐Dąbrowska, B., Międzybrodzki, R., Letkiewicz, S., Fortuna, W., Rogóż, P., Szufnarowski, K., Jończyk‐Matysiak, E., Olchawa, E., et al. (2016) · Future Microbiology · doi:10.2217/fmb-2016-0156 · Cited by 97
Singla, S., Harjai, K., Katare, O. P., & Chhibber, S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv029 · Cited by 96
Uptake and intracellular fate of phage display vectors in mammalian cells
Ivanenkov, V. V., Felici, F., & Menon, A. G. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00162-1 · Cited by 93
Wong, C. L., Sieo, C. C., Tan, W. S., Abdullah, N., Bejo, M. H., Abu, J., & Ho, Y. W. (2013) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2013.11.034 · Cited by 93
Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics
Jończyk‐Matysiak, E., Weber‐Dąbrowska, B., Owczarek, B., Międzybrodzki, R., Łusiak-Szelachowska, M., Łodej, N., & Górski, A. (2017) · Viruses · doi:10.3390/v9060150 · Cited by 92
Nishikawa, H., Yasuda, M., Uchiyama, J., Rashel, M., Maeda, Y., Takemura, I., Sugihara, S., Ujihara, T., Shimizu, Y., Shuin, T., et al. (2008) · Archives of Virology · doi:10.1007/s00705-007-0031-4 · Cited by 88
Takemura‐Uchiyama, I., Uchiyama, J., Osanai, M., Morimoto, N., Asagiri, T., Ujihara, T., Daibata, M., Sugiura, T., & Matsuzaki, S. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.02.011 · Cited by 87
Fate of Bacteriophage Particles Introduced into Mice by Various Routes.
Keller, R., & Engley, F. B. (1958) · Experimental Biology and Medicine · doi:10.3181/00379727-98-24112 · Cited by 85
Jeon, J., Ryu, C., Lee, J.-Y., Park, J., Yong, D., & Lee, K. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00526-16 · Cited by 74
Fogelman, I., Davey, V. J., Ochs, H. D., Elashoff, M. R., Feinberg, M. B., Mican, J. M., Siegel, J. P., Sneller, M. C., & Lane, H. C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315739 · Cited by 71
HUFF, W. E., Huff, G. R., Rath, N. C., & Donoghue, A. M. (2006) · Poultry Science · doi:10.1093/ps/85.8.1373 · Cited by 65
Convection-enhanced delivery of M13 bacteriophage to the brain
Ksendzovsky, A., Walbridge, S., Saunders, R. C., Asthagiri, A. R., Heiss, J. D., & Lonser, R. R. (2012) · Journal of neurosurgery · doi:10.3171/2012.4.jns111528 · Cited by 64
Verth�, K., Possemiers, S., Boon, N., Vaneechoutte, M., & Verstraete, W. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1585-7 · Cited by 62
Wang, Y., Mi, Z., Niu, W., An, X., Yuan, X., Liu, H., Li, P., Liu, Y., Feng, Y., Huang, Y., et al. (2016) · Future Microbiology · doi:10.2217/fmb.16.11 · Cited by 59
Capparelli, R., Ventimiglia, I., Roperto, S., Fenizia, D., & Iannelli, D. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01340.x · Cited by 58
Taking Bacteriophage Therapy Seriously: A Moral Argument
Verbeken, G., Huys, I., Pirnay, J., Jennes, S., Чанішвілі, Н., Scheres, J. M. J. C., Górski, A., Vos, D. D., & Ceulemans, C. (2014) · BioMed Research International · doi:10.1155/2014/621316 · Cited by 58
Immune Response in the Bovine Mammary Gland After Intestinal, Local, and Systemic Immunization
Chang, C. C., Winter, A. J., & Norcross, N. L. (1981) · Infection and Immunity · doi:10.1128/iai.31.2.650-659.1981 · Cited by 57
Sokoloff, A. V., Zhang, G., Sebestyén, M. G., Wolff, J. A., & Bock, I. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0110 · Cited by 56
Reynaud, A., Cloastre, L., Bernard, J., Laveran, H., Ackermann, H., Licois, D., & Joly, B. (1992) · Veterinary Microbiology · doi:10.1016/0378-1135(92)90114-9 · Cited by 55
Pereira, S. P. P., Pereira, C., Santos, L., Klumpp, J., & Almeida, A. (2015) · Virus Research · doi:10.1016/j.virusres.2015.10.025 · Cited by 53
From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea
Sarker, S. A., & Brüssow, H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13087 · Cited by 51
Liu, K.-Y., Yang, W., Dong, X., Cong, L.-M., Li, N., Li, Y., Wen, Z., Yin, Z., Lan, Z.-J., Li, W.-P., et al. (2016) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1233 · Cited by 46
Microneedle-mediated transdermal bacteriophage delivery
Ryan, E. M., Garland, M. J., Singh, T. R. R., Bambury, E., O’Dea, J., Migalska, K., Gorman, S. P., McCarthy, H. O., Gilmore, B., & Donnelly, R. F. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.06.012 · Cited by 45
Abdulamir, A. S., Jassim, S. A., & Bakar, F. A. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-014-0039-z · Cited by 42
Taylor, R. P., Sutherland, W. M., Martin, E. N., Ferguson, P. J., Reinagel, M. L., Gilbert, E., Lopez, K., Incardona, N. L., & Ochs, H. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.842 · Cited by 41
The influence of the mode of administration in the dissemination of three coliphages in chickens
Oliveira, A., Sereno, R., Nicolau, A., & Azeredo, J. (2009) · Poultry Science · doi:10.3382/ps.2008-00378 · Cited by 36
Therapeutic effect of Pseudomonas aeruginosa phage YH30 on mink hemorrhagic pneumonia
Gu, J., Li, X., Yang, M., Du, C., Cui, Z., Gong, P., Xia, F., Song, J. I., Zhang, L., Li, J., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.03.016 · Cited by 32
An In vivo Wound Model Utilizing Bacteriophage Therapy of Pseudomonas aeruginosa Biofilms.
Basu, S., Agarwal, M., Bhartiya, S. K., Nath, G., & Shukla, V. K. (2015) · PubMed · Cited by 31
Costantini, T. W., Putnam, J. G., Sawada, R., Baird, A., Loomis, W. H., Eliceiri, B. P., Bansal, V., & Coimbra, R. S. M. (2009) · Surgery · doi:10.1016/j.surg.2009.05.007 · Cited by 28
Schultz, I., & Neva, F. A. (1965) · The Journal of Immunology · doi:10.4049/jimmunol.94.6.833 · Cited by 27
Hájek, P., & Mandel, L. (1966) · Folia Microbiologica · doi:10.1007/bf02878898 · Cited by 24
Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles
Kłopot, A., Zakrzewska, A., Lecion, D., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02170 · Cited by 22
Occurrence of Serotonin in a Hallucinogenic Mushroom
Tyler, V. E. (1958) · Science · doi:10.1126/science.128.3326.718-a · Cited by 17
Keller, R., & Zatzman, M. L. (1959) · The Journal of Immunology · doi:10.4049/jimmunol.83.2.167 · Cited by 15
The lymph node filter revealed
Hons, M., & Sixt, M. (2015) · Nature Immunology · doi:10.1038/ni.3126 · Cited by 15
Identifying and Analyzing Bacteriophages in Human Fecal Samples: What Could we Discover?
Muniesa, M., & Jofre, J. T. (2014) · Future Microbiology · doi:10.2217/fmb.14.47 · Cited by 14
Localization of cholera bacterio-phage after intravenous injection.
Mukerjee, S., & Ghosh, S. (1962) · PubMed · Cited by 12
THE IN VIVO INTERACTION BETWEEN STAPHYLOCOCCUS BACTERIOPHAGE AND STAPHYLOCOCCUS AUREUS
Bartell, P. F., THIND, I. S., Orr, T. E., et al. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.118.1.13 · Cited by 4
Cited by
Phage therapy: From biological mechanisms to future directions
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K., & Schooley, R. T. (2023) · Cell · doi:10.1016/j.cell.2022.11.017 · Cited by 817
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Considerations for the Use of Phage Therapy in Clinical Practice
Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-21 · Cited by 378
Current challenges and future opportunities of phage therapy
Pires, D. P., Costa, A. R., Pinto, G., Meneses, L., & Azeredo, J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa017 · Cited by 340
Metadata
- Authors
- Dąbrowska, K.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2019-03-19
- Volume
- 39
- Issue
- 5
- Pages
- 2000-2025
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2924332698
- Cited by
- 375
- References
- 145
- FWCI
- 20.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.